Food Allergy News

Researchers found associations between Index of Severity for Eosinophilic Esophagitis scores and select clinical features across categories of disease severity, according to a study published in The Journal of Allergy and Clinical Immunology.

In February, the FDA approved omalizumab for the reduction of food allergic reactions. First approved in 2003 for allergic asthma, this anti-IgE monoclonal antibody developed by Genentech and Novartis inhibits the allergic reaction process.

The risk of developing alopecia areata increases when both seasonal and food allergies are present, according to a study published in The European Journal of Allergy and Clinical Immunology.

Significant disparities exist between patients with peanut allergies who are currently receiving oral immunotherapy and those who are not, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

Families of children with peanut allergies that pursued oral immunotherapy cited remission and the potential for disease modification as their reason, according to a study published in The Journal of Allergy and Immunology: In Practice.

New guidance was established for clinicians in the U.K. in order to implement the use of Palforzia in oral immunotherapy for patients with a peanut allergy, according to a study published in Clinical & Experimental Allergy.

Gut microbiomes in children with food allergy may differ from those without food allergy, with fewer differences seen in younger children, according to a study published in Annals of Allergy, Asthma and Immunology.

The FDA issued a warning against Bimbo Bakeries USA, which includes brands such as Sara Lee and Brownberry among others, on June 25 over incorrect allergy warning labels.

Participants with an allergy to cow’s milk had the lowest rate of oral immunotherapy treatment discontinuation, according to a study published in Annals of Allergy, Asthma and Immunology.

There were significant differences in percentages of children with eosinophilic esophagitis who experienced histologic remission with dupilumab compared with placebo, according to a study published in The New England Journal of Medicine.